ATE127478T1 - Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung. - Google Patents
Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.Info
- Publication number
- ATE127478T1 ATE127478T1 AT88907473T AT88907473T ATE127478T1 AT E127478 T1 ATE127478 T1 AT E127478T1 AT 88907473 T AT88907473 T AT 88907473T AT 88907473 T AT88907473 T AT 88907473T AT E127478 T1 ATE127478 T1 AT E127478T1
- Authority
- AT
- Austria
- Prior art keywords
- growth factor
- factor activity
- production
- encoding polypeptide
- polypeptide possessing
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 239000003102 growth factor Substances 0.000 title abstract 2
- 108700020796 Oncogene Proteins 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/056,137 US5155217A (en) | 1987-05-29 | 1987-05-29 | Ongogene encoding polypeptide having growth factor activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE127478T1 true ATE127478T1 (de) | 1995-09-15 |
Family
ID=22002413
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88907473T ATE127478T1 (de) | 1987-05-29 | 1988-05-26 | Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5155217A (de) |
| EP (1) | EP0317627B1 (de) |
| JP (1) | JP2888846B2 (de) |
| AT (1) | ATE127478T1 (de) |
| AU (1) | AU626268B2 (de) |
| CA (1) | CA1340374C (de) |
| DE (1) | DE3854420T2 (de) |
| DK (1) | DK175211B1 (de) |
| WO (1) | WO1988009378A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7238673B2 (en) | 1989-03-31 | 2007-07-03 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| JP2784272B2 (ja) * | 1990-06-06 | 1998-08-06 | 大正製薬株式会社 | 腫瘍細胞増殖阻害因子 |
| US6551618B2 (en) | 1994-03-15 | 2003-04-22 | University Of Birmingham | Compositions and methods for delivery of agents for neuronal regeneration and survival |
| US6331523B1 (en) | 1998-03-12 | 2001-12-18 | Genentech, Inc. | Method of enhancing the survival of retinal neurons and treating ocular diseases using FGF-5 |
| US8618052B2 (en) | 1998-10-13 | 2013-12-31 | Novartis Vaccines And Diagnostics, Inc. | Method of treating coronary artery disease by administering FGF-5 |
| US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
| US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
| WO2000021548A2 (en) | 1998-10-13 | 2000-04-20 | Chiron Corporation | Angiogenically effective unit dose of fgf and method of administering |
| US20030166550A1 (en) | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
| AU6634400A (en) | 1999-08-13 | 2001-03-13 | Chiron Corporation | Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| US20060009393A1 (en) * | 1999-10-02 | 2006-01-12 | The Government of the U.S.A as represented by the Secretary of the Dept. of Health & Human Services | Immunogenic epitopes for fibroblast growth factors 5 (FGF-5) |
-
1987
- 1987-05-29 US US07/056,137 patent/US5155217A/en not_active Expired - Lifetime
-
1988
- 1988-05-26 JP JP63506808A patent/JP2888846B2/ja not_active Expired - Lifetime
- 1988-05-26 AU AU22628/88A patent/AU626268B2/en not_active Expired
- 1988-05-26 AT AT88907473T patent/ATE127478T1/de not_active IP Right Cessation
- 1988-05-26 WO PCT/US1988/001767 patent/WO1988009378A2/en active IP Right Grant
- 1988-05-26 EP EP88907473A patent/EP0317627B1/de not_active Expired - Lifetime
- 1988-05-26 DE DE3854420T patent/DE3854420T2/de not_active Expired - Lifetime
- 1988-05-27 CA CA000567999A patent/CA1340374C/en not_active Expired - Fee Related
-
1989
- 1989-01-27 DK DK198900388A patent/DK175211B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK38889D0 (da) | 1989-01-27 |
| JPH01503518A (ja) | 1989-11-30 |
| DK38889A (da) | 1989-01-27 |
| WO1988009378A2 (en) | 1988-12-01 |
| WO1988009378A3 (en) | 1988-12-15 |
| EP0317627B1 (de) | 1995-09-06 |
| EP0317627A4 (en) | 1990-12-12 |
| EP0317627A1 (de) | 1989-05-31 |
| DE3854420D1 (de) | 1995-10-12 |
| CA1340374C (en) | 1999-02-02 |
| AU626268B2 (en) | 1992-07-30 |
| US5155217A (en) | 1992-10-13 |
| AU2262888A (en) | 1988-12-21 |
| JP2888846B2 (ja) | 1999-05-10 |
| DE3854420T2 (de) | 1996-05-02 |
| DK175211B1 (da) | 2004-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3587422D1 (de) | Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins. | |
| DE3769094D1 (de) | Verfahren zur herstellung von aromatischen kohlenwasserstoffen, das die verwendung von nebenprodukten umfasst. | |
| DE3872273D1 (de) | Verfahren zur herstellung und verwendung von kohlenstoffmolekularsieben. | |
| DE3585953D1 (de) | Dna-fragmente, expressionsvektoren, proteine, wirte und verfahren zur herstellung der proteine. | |
| DE3583194D1 (de) | Verfahren zur herstellung von einem polypeptid mittels eines transformierten mikroorganismus, ein dazu geeigneter transformierter mikroorganismus, und zur herstellung dieser mikroorganismen geeignete dns sequenzen. | |
| DE3675687D1 (de) | Verfahren zur herstellung von 2,2,6,6,-tetraalkyl-4-piperidylamine. | |
| DE3869920D1 (de) | Verfahren zur herstellung von 1,1-dichlor-1,2,2,2-tetrafluoraethan. | |
| DE3774035D1 (de) | Verfahren zur herstellung von pech, verwertbar zur herstellung von kohlenstoffkoerpern. | |
| DE3880440D1 (de) | Verfahren zur herstellung von apoaequorin. | |
| ATE127478T1 (de) | Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung. | |
| DE3676215D1 (de) | Verfahren zur herstellung von 2,3,4,5-tetrafluorbenzoesaeure. | |
| DE3860671D1 (de) | Verfahren zur herstellung von 2,6-dialkylnaphthalin. | |
| DE3861825D1 (de) | Verfahren zur herstellung von (2,2)-paracyclophan. | |
| DE3673049D1 (de) | Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon. | |
| DE58905117D1 (de) | Verfahren zur herstellung von 4-chlor-2,5-dimethoxyanilin. | |
| DE3768426D1 (de) | Verfahren zur herstellung von 4,4'-biphenyldicarbonsaeure. | |
| DE3751081D1 (de) | [Leu 13] Motilin, dessen kodierende DNS-Moleküle und Verfahren zu dessen Herstellung. | |
| DE3860105D1 (de) | Verfahren zur herstellung von 4,4'-dichlordiphenylsulfonen. | |
| DE3586940D1 (de) | Polypeptid und dessen verfahren zur herstellung. | |
| DE3778329D1 (de) | Verfahren zur herstellung von 2,6-dichlorobenzonitril. | |
| DE58901165D1 (de) | Verfahren zur herstellung von 2,4-dihydroxybenzoesaeure. | |
| DE3578862D1 (de) | Verfahren zur herstellung von 5,6,7,8-tetrahydrofolsaeure. | |
| DE3786870D1 (de) | Methode zur herstellung von proteinen. | |
| DE3874496D1 (de) | Verfahren zur herstellung von 4,4'-dibrombiphenyl. | |
| DE3673492D1 (de) | Verfahren zur herstellung von alpha,alpha-dimethyl-delta-valerolacton. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EELA | Cancelled due to lapse of time |